Showing results (81-90 of 211) with videos related to
Sort By:
Pageof 22
Pancreas|May 24, 2012
Risk factors for hepatic steatosis after pancreatectomy: a retrospective observational cohort study of the importance of nutritional managementYukiyasu Okamura, Hiroyuki Sugimoto, Suguru Yamada, et al.Journal of Hepato-Biliary-Pancreatic Surgery|March 17, 2009
Small-cell carcinoma in the common bile duct treated with multidisciplinary managementYukiyasu Okamura, Atsuyuki Maeda, Kazuya Matsunaga, et al.Journal of Hepato-Biliary-Pancreatic Surgery|March 17, 2009
Hepatocellular adenoma in a male with familial adenomatous polyposis coliYukiyasu Okamura, Atsuyuki Maeda, Kazuya Matsunaga, et al.World Journal of Surgery|November 1, 2018
Left Hepatectomy with Combined Resection and Reconstruction of Right Hepatic Artery for Bismuth Type I and II Perihilar CholangiocarcinomaTeiichi Sugiura, Yukiyasu Okamura, Takaaki Ito, et al.Annals of Surgical Oncology|January 24, 2021
Clinical Significance of Preoperative Albumin-Bilirubin Grade in Pancreatic CancerTaisuke Imamura, Yukiyasu Okamura, Teiichi Sugiura, et al.Surgical Case Reports|February 1, 2020
A case of perihilar cholangiocarcinoma with bilateral ligamentum teres hepatis treated with hepatopancreatoduodenectomyFumihiro Terasaki, Yusuke Yamamoto, Teiichi Sugiura, et al.Annals of Gastroenterological Surgery|July 18, 2022
Clinical implications of lymphadenectomy for invasive ductal carcinoma of the body or tail of the pancreasTakuya Minagawa, Teiichi Sugiura, Yukiyasu Okamura, et al.Annals of Surgical Oncology|November 10, 2009
Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysisShuji Nomoto, Mitsuro Kanda, Yukiyasu Okamura, et al.Surgery|October 28, 2015
Is combined pancreatoduodenectomy for advanced gallbladder cancer justified?Yusuke Yamamoto, Teiichi Sugiura, Yukiyasu Okamura, et al.World Journal of Surgery|April 6, 2018
Surgical Indication for Advanced Intrahepatic Cholangiocarcinoma According to the Optimal Preoperative Carbohydrate Antigen 19-9 Cutoff ValueYusuke Yamamoto, Teiichi Sugiura, Akiko Todaka, et al.Pageof 22